Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_assertion type Assertion NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_head.
- NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_assertion description "[The ORs for the MUTYH Gln324His and the APEX1 Asp148Glu were statistically significant for colon cancer (adjusted OR 3.95, 95%CI 1.28-12.20, p = 0.017 for MUTYH Gln324His ; adjusted OR 3.04, 95%CI 1.38-6.71, p = 0.006 for APEX1 Asp148Glu).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_provenance.
- NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_assertion evidence source_evidence_literature NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_provenance.
- NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_assertion SIO_000772 18823566 NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_provenance.
- NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_assertion wasDerivedFrom befree-20150227 NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_provenance.
- NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_assertion wasGeneratedBy ECO_0000203 NP580072.RAjPGQl15pGyY5RQFAqQyds0vA6vQIk4nJrV9PnLjSv-g130_provenance.